AJICAP-M: Traceless Affinity Peptide Mediated Conjugation Technology for Site-Specific Antibody-Drug Conjugate Synthesis
Authors:
- Yutaka MatsudaYMYutaka Matsuda
- Natsuki ShikidaNSNatsuki Shikida
- Noriko HatadaNHNoriko Hatada
- Kei YamadaKYKei Yamada
- Takuya SekiTSTakuya Seki
- Yuichi NakaharaYNYuichi Nakahara
- Yuta EndoYEYuta Endo
- Kazutaka ShimboKSKazutaka Shimbo
- Kazutoshi TakahashiKTKazutoshi Takahashi
- Akira NakayamaANAkira Nakayama
- Brian A. MendelsohnBMBrian A. Mendelsohn
- Tomohiro FujiiTFTomohiro Fujii
Preprint
- 12 March 2024
- preprint
- Published by American Chemical Society (ACS) in ChemRxiv
Abstract
A traceless site-selective conjugation method, “AJICAP-M,” was developed for native antibodies at specific sites using Fc-affinity peptides, focusing on Lys248 or Lys288. It produces antibody-drug conjugates (ADCs) with consistent drug-to-antibody ratios, enhanced stability, and simplified manufacturing. Comparative in vivo assessment demonstrated AJICAP-M's superior stability over traditional ADCs. This technology has been successfully applied to continuous-flow manufacturing, marking the first achievement in site-specific ADC production. This manuscript outlines AJICAP-M's methodology and its effectiveness in ADC production.Keywords
All Related Versions
- Version 1, 2024-03-12, ChemRxiv
- Published version: Organic Letters, 26 (27), 5597.
This publication has 16 references indexed in Scilit:
- The Evolving Landscape of Antibody–Drug Conjugates: In Depth Analysis of Recent Research ProgressBioconjugate Chemistry, 2023
- Drug-Linkers in Antibody–Drug Conjugates: Perspective on Current Industry PracticesOrganic Process Research & Development, 2023
- The Dawn of a New Era: Targeting the “Undruggables” with Antibody-Based TherapeuticsChemical Reviews, 2023
- AJICAP Second Generation: Improved Chemical Site-Specific Conjugation Technology for Antibody–Drug Conjugate ProductionBioconjugate Chemistry, 2023
- Tag‐Free Enzymatic Modification for Antibody−Drug Conjugate ProductionChemistrySelect, 2022
- Site-Selective Lysine Acetylation of Human Immunoglobulin G for Immunoliposomes and Bispecific Antibody ComplexesJournal of the American Chemical Society, 2022
- Site-Selective Antibody–Drug Conjugation by a Proximity-Driven S to N Acyl Transfer Reaction on a Therapeutic AntibodyJournal of Medicinal Chemistry, 2022
- Lipoate-acid ligase a modification of native antibody: Synthesis and conjugation site analysisBioorganic & Medicinal Chemistry Letters, 2021
- Linker Architectures as Steric Auxiliaries for Altering Enzyme-Mediated Payload Release from BioconjugatesBioconjugate Chemistry, 2021
- An autonomous molecular assembler for programmable chemical synthesisNature Chemistry, 2016